{"id":"eu-approved-roactemra","safety":{"commonSideEffects":[{"rate":"15-25","effect":"Infections (including serious infections)"},{"rate":"10-20","effect":"Elevated liver enzymes (ALT/AST)"},{"rate":"10-15","effect":"Hyperlipidemia"},{"rate":"5-10","effect":"Neutropenia"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Hypertension"},{"rate":"<1","effect":"Gastrointestinal perforation (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tocilizumab binds to both membrane-bound and soluble IL-6 receptors on immune cells and endothelial cells, inhibiting IL-6-mediated signal transduction. This suppresses the production of pro-inflammatory cytokines and adhesion molecules, thereby reducing systemic inflammation and immune activation in autoimmune and inflammatory conditions.","oneSentence":"RoActemra (tocilizumab) is a humanized monoclonal antibody that blocks the interleukin-6 (IL-6) receptor, reducing inflammatory signaling in immune-mediated diseases.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:46:32.001Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Giant cell arteritis"},{"name":"Polyarticular juvenile idiopathic arthritis"},{"name":"Systemic sclerosis-associated interstitial lung disease"},{"name":"COVID-19 (severe or critical)"}]},"trialDetails":[{"nctId":"NCT01394276","phase":"","title":"An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-05","conditions":"Rheumatoid Arthritis","enrollment":322},{"nctId":"NCT05489224","phase":"PHASE3","title":"A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Celltrion","startDate":"2022-09-14","conditions":"Rheumatoid Arthritis","enrollment":471},{"nctId":"NCT04512001","phase":"PHASE3","title":"MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Fresenius Kabi SwissBioSim GmbH","startDate":"2020-08-03","conditions":"Rheumatoid Arthritis","enrollment":604},{"nctId":"NCT05188378","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects","status":"UNKNOWN","sponsor":"Celltrion","startDate":"2021-12-22","conditions":"Healthy Subjects","enrollment":300},{"nctId":"NCT03282851","phase":"PHASE1","title":"Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456","status":"COMPLETED","sponsor":"Fresenius Kabi SwissBioSim GmbH","startDate":"2017-11-27","conditions":"Healthy","enrollment":696},{"nctId":"NCT03522012","phase":"PHASE1","title":"Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers","status":"COMPLETED","sponsor":"Mycenax Biotech Inc.","startDate":"2017-10-17","conditions":"Pharmacokinetics","enrollment":190}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"EU-approved RoActemra","genericName":"EU-approved RoActemra","companyName":"Fresenius Kabi SwissBioSim GmbH","companyId":"fresenius-kabi-swissbiosim-gmbh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"RoActemra (tocilizumab) is a humanized monoclonal antibody that blocks the interleukin-6 (IL-6) receptor, reducing inflammatory signaling in immune-mediated diseases. Used for Rheumatoid arthritis, Giant cell arteritis, Polyarticular juvenile idiopathic arthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}